CLINICAL_TRIALS
trial_result
· 2012-04-04
Clinical Trial Update: Lucentis KAV Study [Phase 3]
Summary
An update on a Phase 3 clinical trial of Lucentis (ranibizumab) for age-related macular degeneration. The study has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery | Conditions: Age Related Macular Degeneration | Phase 3 | Status: COMPLETED